AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Evogene Ltd.

Foreign Filer Report Jul 23, 2024

6785_rns_2024-07-23_aa35b48e-e657-46c6-82d8-4eb998a378a5.htm

Foreign Filer Report

Open in Viewer

Opens in native device viewer

_________ false

����� ��"� 2 381
EVOGENE LTD
Corporation no: 512838723 13041
- - -
Israel Securities Authority Tel Aviv Stock Exchange C003 ( Public ) Reported via MAGNA: 23/07/2024
www.isa.gov.il www.tase.co.il Reference: 2024-02-077623 Time of broadcast: 10:53 10:53

Amended report for distorted report sent on date 17/07/2024 Whose reference number was: 2024-02-075151

The distortion: ���� ����� ����� ������
The distortion cause: ������ ���� ����� �� ����'� ����
The main amendment: ������ ���� ����� �� ����'� ����

The corporation scheduled the publication of the report to 23/07/2024 11:15Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on ����� ����� ����� ������ ����� ���� ��� ������ 17 ����� 2024

ment_July_23_clean_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 18/06/2024
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected]   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Kofman Guy Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company:
Address: Gad Feinstein St. 13 , Rehovot 7638517 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: [email protected] 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.